Vogt Keith M, Simmons Marcus A, Reddy Sujatha N, Burlew Alex C, Kozdron Courtney N, Lavage Danielle R, Wang Sheri, Pryor Kane O, Shafer Steven L, Ibrahim Tamer, Aizenstein Howard J, Reder Lynne M, Ibinson James W, Fiez Julie A
Department of Anesthesiology and Perioperative Medicine, School of Medicine, and Department of Bioengineering, Swanson School of Engineering, and Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, Pennsylvania; Center for the Neural Basis of Cognition, Pittsburgh, Pennsylvania.
Department of Anesthesiology and Perioperative Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Anesthesiology. 2025 Aug 1;143(2):313-329. doi: 10.1097/ALN.0000000000005489. Epub 2025 Apr 9.
Anesthetic agents are well known for their effects on memory and pain; however, previous studies quantifying anesthetic modulation of memory have not included experimental noxious stimulation. This study used functional magnetic resonance imaging to determine how low doses of propofol, dexmedetomidine, and fentanyl affect the brain systems for memory encoding and pain perception.
This was a single-blind, 1:1:1, randomized, placebo-controlled crossover study of 92 healthy volunteers ages 18 to 40 yr. Effect-site concentrations were targeted for propofol (1.0 mcg/ml), dexmedetomidine (0.15 ng/ml), or fentanyl (0.9 ng/ml). Participants listened to a series of 80 words creating a mental picture. Thirty were accompanied by a 2-s painful shock. Blood oxygen-weighted images were obtained at 7 T using a custom head coil. The primary outcome was next-day memory performance, measured by d', a normalized measure of correct identifications versus false positives. Mixed models were fit to test outcome differences between drug groups. Only statistically significant ( P < 0.05) changes are reported, after adjustment for multiple comparisons.
Recollection, reported as mean d' (95% CI), was 1.16 (95% CI, 0.97 to 1.34) under no drug. This was reduced under propofol (0.51; 95% CI, 0.182 to 0.842; P = 0.006) but not under dexmedetomidine (1.04; 95% CI, 0.73 to 1.35; P = 0.99) or fentanyl (0.98; 95% CI, 0.68 to 1.28; P = 0.99). Propofol decreased memory-encoding activation of the hippocampus and amygdala. Propofol reduced pain-related activation in the insula, anterior cingulate, hippocampus, and amygdala. Dexmedetomidine showed decreased memory-related activation in the hippocampus but did not change pain ratings or show activation differences in pain-processing areas. Fentanyl showed decreased memory activation in the hippocampus and amygdala. During painful stimulation, fentanyl decreased activation in the primary somatosensory cortex and insula and increased activation in the anterior cingulate, hippocampus, and amygdala.
These findings add important details to the complex framework of how these distinct anesthetics affect different aspects of cognition through diverse neuroanatomic targets in the brain.
麻醉剂对记忆和疼痛的影响广为人知;然而,以往量化麻醉剂对记忆调节作用的研究未纳入实验性有害刺激。本研究采用功能磁共振成像来确定低剂量丙泊酚、右美托咪定和芬太尼如何影响记忆编码和疼痛感知的脑系统。
这是一项针对92名年龄在18至40岁的健康志愿者的单盲、1:1:1、随机、安慰剂对照交叉研究。目标效应室浓度为丙泊酚(1.0微克/毫升)、右美托咪定(0.15纳克/毫升)或芬太尼(0.9纳克/毫升)。参与者听一系列80个单词并形成心理图像。其中30个单词伴有2秒的疼痛电击。使用定制头部线圈在7T下获取血氧水平依赖图像。主要结局是次日的记忆表现,通过d'进行测量,d'是正确识别与假阳性的标准化指标。采用混合模型来检验药物组之间的结局差异。经多重比较调整后,仅报告具有统计学意义(P<0.05)的变化。
在未用药情况下,记忆回想以平均d'(95%CI)表示为1.16(95%CI,0.97至1.34)。丙泊酚作用下该值降低(0.51;95%CI,0.182至0.842;P = 0.006),但右美托咪定(1.04;95%CI,0.73至1.35;P = 0.99)或芬太尼(0.98;95%CI,0.68至1.28;P = 0.99)作用下未降低。丙泊酚降低了海马体和杏仁核的记忆编码激活。丙泊酚减少了岛叶、前扣带回、海马体和杏仁核中与疼痛相关的激活。右美托咪定显示海马体中与记忆相关的激活减少,但未改变疼痛评分,也未显示疼痛处理区域的激活差异。芬太尼显示海马体和杏仁核中的记忆激活减少。在疼痛刺激期间,芬太尼减少了初级体感皮层和岛叶的激活,并增加了前扣带回、海马体和杏仁核的激活。
这些发现为这些不同麻醉剂如何通过大脑中不同的神经解剖靶点影响认知的不同方面这一复杂框架增添了重要细节。